Rossella Renso
Vimercate, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The Effects of a Modified Mediterranean Diet on Gut Microbiota and Chemotherapy Side Effects in Patients With Metastatic Colorectal Cancer Undergoing First-Line Chemotherapy With or Without Either Antiepidermal Growth Factor Receptor or Antivascular Endothelial Growth Factor Agent: Protocol for a Randomized Pilot Study in Italy.
Journal: JMIR research protocols
Published: February 21, 2025
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial.
Journal: American journal of hematology
Published: April 11, 2024
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study.
Journal: British journal of haematology
Published: August 17, 2021
Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study.
Journal: Frontiers in oncology
Published: February 15, 2021
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy.
Journal: American journal of hematology
Published: August 06, 2020
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine.
Journal: Nature communications
Published: August 19, 2019
Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea.
Journal: Blood cancer journal
Published: January 01, 2018
Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: kinetics of its appearance and potential predictive role in infectious complications.
Journal: Leukemia research
Published: August 17, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026